Our group is focused on seeking novel approaches for lung repair and regeneration. Our focus is on non-viral gene therapy and stem cell based approaches. Our aim is to apply stem cell secretome for lung repair and regeneration in clinical settings. Moreover, we are working to develop a non-viral method that can delivery chemotherapeutics, biologics and genes in a localized targeted manner directly in the cells. To understand pathophysiology of lung disease there are no proper animal models, to align with the 3R regulations we try to develop disease specific lung organoids that can be used to understand disease mechanisms and for drug screening.